212 related articles for article (PubMed ID: 36823373)
21. GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.
Kyrönlahti A; Rämö M; Tamminen M; Unkila-Kallio L; Butzow R; Leminen A; Nemer M; Rahman N; Huhtaniemi I; Heikinheimo M; Anttonen M
Endocrinology; 2008 Nov; 149(11):5635-42. PubMed ID: 18653721
[TBL] [Abstract][Full Text] [Related]
22. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
Chen L; Yang B
Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
[TBL] [Abstract][Full Text] [Related]
23. SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?
Fang X; Gao Y; Li Q
Biol Reprod; 2016 Nov; 95(5):105. PubMed ID: 27683263
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
25. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
Rosario R; Araki H; Print CG; Shelling AN
PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
Cheng JC; Klausen C; Leung PC
PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
[TBL] [Abstract][Full Text] [Related]
27. The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin.
Dhillon VS; Aslam M; Husain SA
Clin Cancer Res; 2004 Aug; 10(16):5537-45. PubMed ID: 15328194
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.
Wang C; Lv X; Jiang C; Cordes CM; Fu L; Lele SM; Davis JS
PLoS One; 2012; 7(11):e48299. PubMed ID: 23155381
[TBL] [Abstract][Full Text] [Related]
29. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
30. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
[TBL] [Abstract][Full Text] [Related]
31. The molecular mechanism of ovarian granulosa cell tumors.
Li J; Bao R; Peng S; Zhang C
J Ovarian Res; 2018 Feb; 11(1):13. PubMed ID: 29409506
[TBL] [Abstract][Full Text] [Related]
32. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
33. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
Bittinger S; Alexiadis M; Fuller PJ
Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
[TBL] [Abstract][Full Text] [Related]
34. Adult granulosa cell tumors of bilateral ovaries with pure cystic presentation: A case report and review of literature.
Wang B; Xu X; Zhao Z; Yao D; Qi L; Zhou Y
Medicine (Baltimore); 2020 Oct; 99(40):e22511. PubMed ID: 33019452
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition.
Andersson N; Anttonen M; Färkkilä A; Pihlajoki M; Bützow R; Unkila-Kallio L; Heikinheimo M
J Mol Endocrinol; 2014 Apr; 52(2):223-34. PubMed ID: 24463098
[TBL] [Abstract][Full Text] [Related]
36. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
37. Inhibitor of apoptosis proteins are potential targets for treatment of granulosa cell tumors - implications from studies in KGN.
Bagnjuk K; Kast VJ; Tiefenbacher A; Kaseder M; Yanase T; Burges A; Kunz L; Mayr D; Mayerhofer A
J Ovarian Res; 2019 Aug; 12(1):76. PubMed ID: 31412918
[TBL] [Abstract][Full Text] [Related]
38. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.
Chu S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2008 Jan; 108(1):182-90. PubMed ID: 18028988
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
Kim MS; Hur SY; Yoo NJ; Lee SH
J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
[TBL] [Abstract][Full Text] [Related]
40. Comparative immunohistochemical analysis of granulosa and sertoli components in ovarian sex cord-stromal tumors with mixed differentiation: potential implications for derivation of sertoli differentiation in ovarian tumors.
Vang R; Herrmann ME; Tavassoli FA
Int J Gynecol Pathol; 2004 Apr; 23(2):151-61. PubMed ID: 15084844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
